UNSPSC 51282111: Penamecillin

This classification denotes a benzylpenicillin acetoxymethyl ester and penicillin g analog with the molecular formula C19H22N2O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H0P1YE5581, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-(2s-(2alpha,5alpha,6beta))-, (acetyloxy)methyl ester but generally known as penamecillin, which bears US NIH Compound Identifier 13795.

UNSPSC 51282111 Penamecillin is a Commodity code that encompasses pharmaceutical products, but recent state and local solicitations tagged under this code show minimal activity directly aligned with penamecillin itself; instead, the tagged opportunities reflect a broader mix of pharmaceutical procurement including naloxone, generic multi-source drugs, OTC products, and pharmacy benefit program administration. State and local buyers using this code span health departments, county public health agencies, fire and rescue divisions, and cooperative purchasing alliances serving multiple jurisdictions. The scope of work includes emergency medical supplies and medications for first-responder use, generic pharmaceutical procurement through established wholesaler networks, and exploratory contracting for direct-to-manufacturer prescription programs.

Activity appears concentrated in Florida and Minnesota, with emerging interest in Texas. Recent opportunities include Seminole County, Florida's IFB for naloxone and drug deactivation systems (1,900 units annually, due July 26, 2023), the City of Tampa's competitive bid for medical and first aid supplies for the Fire Department Rescue Division (169 line items, estimated contract value $700,000.00, designated as a sheltered market for certified Small Local Business Enterprises with a 5% bid discount, due March 13, 2026), the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products through authorized wholesalers (proposals due March 26, 2026, contract effective July 1, 2026), and the Texas Health and Human Services Commission's RFI on direct-to-manufacturer prescription programs (posted April 3, 2026). The code's recent activity reflects fragmented, ad-hoc pharmaceutical procurement rather than concentrated penamecillin sourcing, suggesting this Commodity code may be misaligned with actual vendor product lines or that penamecillin represents a minor subset of pharmaceutical buys state and local agencies are executing.